Cargando…

Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer

Detalles Bibliográficos
Autores principales: Alves, Carla L., Ehmsen, Sidse, Terp, Mikkel G., Portman, Neil, Tuttolomondo, Martina, Gammelgaard, Odd L., Hundebøl, Monique F., Kaminska, Kamila, Johansen, Lene E., Bak, Martin, Honeth, Gabriella, Bosch, Ana, Lim, Elgene, Ditzel, Henrik J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446011/
https://www.ncbi.nlm.nih.gov/pubmed/34531405
http://dx.doi.org/10.1038/s41467-021-25901-z
_version_ 1784568783693676544
author Alves, Carla L.
Ehmsen, Sidse
Terp, Mikkel G.
Portman, Neil
Tuttolomondo, Martina
Gammelgaard, Odd L.
Hundebøl, Monique F.
Kaminska, Kamila
Johansen, Lene E.
Bak, Martin
Honeth, Gabriella
Bosch, Ana
Lim, Elgene
Ditzel, Henrik J.
author_facet Alves, Carla L.
Ehmsen, Sidse
Terp, Mikkel G.
Portman, Neil
Tuttolomondo, Martina
Gammelgaard, Odd L.
Hundebøl, Monique F.
Kaminska, Kamila
Johansen, Lene E.
Bak, Martin
Honeth, Gabriella
Bosch, Ana
Lim, Elgene
Ditzel, Henrik J.
author_sort Alves, Carla L.
collection PubMed
description
format Online
Article
Text
id pubmed-8446011
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-84460112021-10-04 Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer Alves, Carla L. Ehmsen, Sidse Terp, Mikkel G. Portman, Neil Tuttolomondo, Martina Gammelgaard, Odd L. Hundebøl, Monique F. Kaminska, Kamila Johansen, Lene E. Bak, Martin Honeth, Gabriella Bosch, Ana Lim, Elgene Ditzel, Henrik J. Nat Commun Publisher Correction Nature Publishing Group UK 2021-09-16 /pmc/articles/PMC8446011/ /pubmed/34531405 http://dx.doi.org/10.1038/s41467-021-25901-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Publisher Correction
Alves, Carla L.
Ehmsen, Sidse
Terp, Mikkel G.
Portman, Neil
Tuttolomondo, Martina
Gammelgaard, Odd L.
Hundebøl, Monique F.
Kaminska, Kamila
Johansen, Lene E.
Bak, Martin
Honeth, Gabriella
Bosch, Ana
Lim, Elgene
Ditzel, Henrik J.
Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer
title Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer
title_full Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer
title_fullStr Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer
title_full_unstemmed Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer
title_short Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer
title_sort publisher correction: co-targeting cdk4/6 and akt with endocrine therapy prevents progression in cdk4/6 inhibitor and endocrine therapy-resistant breast cancer
topic Publisher Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446011/
https://www.ncbi.nlm.nih.gov/pubmed/34531405
http://dx.doi.org/10.1038/s41467-021-25901-z
work_keys_str_mv AT alvescarlal publishercorrectioncotargetingcdk46andaktwithendocrinetherapypreventsprogressionincdk46inhibitorandendocrinetherapyresistantbreastcancer
AT ehmsensidse publishercorrectioncotargetingcdk46andaktwithendocrinetherapypreventsprogressionincdk46inhibitorandendocrinetherapyresistantbreastcancer
AT terpmikkelg publishercorrectioncotargetingcdk46andaktwithendocrinetherapypreventsprogressionincdk46inhibitorandendocrinetherapyresistantbreastcancer
AT portmanneil publishercorrectioncotargetingcdk46andaktwithendocrinetherapypreventsprogressionincdk46inhibitorandendocrinetherapyresistantbreastcancer
AT tuttolomondomartina publishercorrectioncotargetingcdk46andaktwithendocrinetherapypreventsprogressionincdk46inhibitorandendocrinetherapyresistantbreastcancer
AT gammelgaardoddl publishercorrectioncotargetingcdk46andaktwithendocrinetherapypreventsprogressionincdk46inhibitorandendocrinetherapyresistantbreastcancer
AT hundebølmoniquef publishercorrectioncotargetingcdk46andaktwithendocrinetherapypreventsprogressionincdk46inhibitorandendocrinetherapyresistantbreastcancer
AT kaminskakamila publishercorrectioncotargetingcdk46andaktwithendocrinetherapypreventsprogressionincdk46inhibitorandendocrinetherapyresistantbreastcancer
AT johansenlenee publishercorrectioncotargetingcdk46andaktwithendocrinetherapypreventsprogressionincdk46inhibitorandendocrinetherapyresistantbreastcancer
AT bakmartin publishercorrectioncotargetingcdk46andaktwithendocrinetherapypreventsprogressionincdk46inhibitorandendocrinetherapyresistantbreastcancer
AT honethgabriella publishercorrectioncotargetingcdk46andaktwithendocrinetherapypreventsprogressionincdk46inhibitorandendocrinetherapyresistantbreastcancer
AT boschana publishercorrectioncotargetingcdk46andaktwithendocrinetherapypreventsprogressionincdk46inhibitorandendocrinetherapyresistantbreastcancer
AT limelgene publishercorrectioncotargetingcdk46andaktwithendocrinetherapypreventsprogressionincdk46inhibitorandendocrinetherapyresistantbreastcancer
AT ditzelhenrikj publishercorrectioncotargetingcdk46andaktwithendocrinetherapypreventsprogressionincdk46inhibitorandendocrinetherapyresistantbreastcancer